Try our Advanced Search for more refined results
In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Kirkland & Ellis
- Gustafson Gluek
- Wilson Sonsini
- Smith Segura Raphael & Leger
- Durrette Arkema
- Girard Sharp
- Zelle LLP
- Garwin Gerstein
- Lockridge Grindal
- McGuireWoods
- Motley Rice
- Joseph Saveri Law Firm
- Kaufman & Canoles
- Ventker Henderson
- Heins Mills
- DurretteCrump
- Duncan & Allen
- Fisher & Phillips
- Faruqi & Faruqi
- O'Hagan Meyer
- Wexler Boley
- Glasser & Glasser
- Williams & Connolly
- Grabar Law
- Hagens Berman
- Marcus & Shapira
- Willcox & Savage
- BoiesBattin
- The Office of Craig C. Reilly
- Nussbaum Law Group
- Crenshaw Ware
- Kessler Topaz
- Hartley LLP
- Furniss Davis
- Katten Muchin
- Hangley Aronchick
- Gibson Dunn
- Morgan Lewis
- Woods Rogers
- Taus Cebulash
- Winston & Strawn
- Goldman Ismail
- Boies Schiller
- Crowell & Moring
- Radice Law Firm
- Cohen Milstein
- Sperling Kenny
- Miller Shah
- McDermott Will & Emery
- Wolcott Rivers
- Berger Montague
- DLA Piper
- Glancy Prongay
- Labaton Keller
- White & Case
Companies
- J.M. Smith Corp.
- WellCare Health Plans Inc.
- Merck & Co. Inc.
- Fraternal Order of Police
- Health Net Inc.
- H.D. Smith LLC
- Glenmark Pharmaceuticals Ltd.
- Giant Eagle Inc.
- Humana Inc.
- Mutual Drug
- Albertsons Cos. Inc.
- Supervalu Inc.
- Par Pharmaceutical Cos. Inc.
- Rochester Drug Cooperative Inc.
- CVS Health Corp.
- United Food & Commercial Workers International Union
- Cardinal Health Inc.
- Zydus Pharmaceuticals Inc.
- Wegmans Food Markets Inc.
- Cencora Inc.
- Centene Corp.
- The Kroger Co.
- McKesson Corp.
- Rite Aid Corp.
- H‑E‑B LP
Sectors & Industries:
-
November 02, 2018
Zetia MDL Buyers Maintain Merck's Generic Deal Was Illegal
A Virginia federal court shouldn't throw out multidistrict litigation accusing Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. of manipulating the generic drug market to keep prices of the cholesterol medication Zetia high, buyers of the drug urged, claiming they can prove antitrust violations.
-
October 12, 2018
Merck, Glenmark Tear Apart Zetia Pay-For-Delay MDL Claims
Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. have asked a Virginia federal court to throw out three complaints in multidistrict litigation accusing them of entering into an illegal reverse-payment deal to keep a generic version of the cholesterol drug Zetia off the market.
-
July 30, 2018
Lawyers Compete To Represent Zetia Buyers In Antitrust Case
More than a half-dozen law firms representing buyers of the cholesterol drug Zetia launched competing bids Friday to act as interim counsel for end payors for the drug in an antitrust MDL accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.
-
July 03, 2018
Direct Drug Purchasers Aim For Consolidation In Zetia MDL
A putative class of direct purchasers of the cholesterol drug Zetia asked a Virginia federal judge on Monday to consolidate their antitrust claims accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.